What criteria do decision makers in Thailand use to set priorities for vaccine introduction?

BackgroundThere is a need to identify rational criteria and set priorities for vaccines. In Thailand, many licensed vaccines are being considering for introduction into the Expanded Program on Immunization; thus, the government has to make decisions about which vaccines should be adopted. This study aimed to set priorities for new vaccines and to facilitate decision analysis.MethodsWe used a best-worst scaling study for rank-ordering of vaccines. The candidate vaccines were determined by a set of criteria, including burden of disease, target age group, budget impact, side effect, effectiveness, severity of disease, and cost of vaccine. The criteria were identified from a literature review and by in-depth, open-ended interviews with experts. The priority-setting model was conducted among three groups of stakeholders, including policy makers, healthcare professionals and healthcare administrators. The vaccine data were mapped and then calculated for the probability of selection.ResultsFrom the candidate vaccines, the probability of hepatitis B vaccine being selected by all respondents (96.67 %) was ranked first. This was followed, respectively, by pneumococcal conjugate vaccine-13 (95.09 %) and Haemophilus influenzae type b vaccine (90.87 %). The three groups of stakeholders (policy makers, healthcare professionals and healthcare administrators) showed the same ranking trends. Most severe disease, high fever rate and high disease burden showed the highest coefficients for criterion levels being selected by all respondents. This result can be implied that a vaccine which can prevent most severe disease with high disease burden and has low safety has a greater chance of being selected by respondents in this study.ConclusionsThe priority setting of vaccines through a multiple-criteria approach could contribute to transparency and accountability in the decision-making process. This is a step forward in the development of an evidence-based approach that meets the need of developing country. The methodology is generalizable but its application to another country would require the criteria as relevant to that country.

[1]  Charung Muangchana,et al.  Incorporation of private demand into cost-benefit analysis of a universal Hib vaccination program in Thailand. , 2011, The Southeast Asian journal of tropical medicine and public health.

[2]  R. Viney,et al.  Funding of drugs: do vaccines warrant a different approach? , 2009, The Lancet. Infectious diseases.

[3]  M. Jit,et al.  Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries , 2012, BMC Public Health.

[4]  J. Louviere,et al.  Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.

[5]  Andrew Lloyd,et al.  Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6]  M. Verweij,et al.  Criteria for inclusion of vaccinations in public programmes. , 2010, Vaccine.

[7]  Richard Emsley,et al.  Applying Best-Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer. , 2012, Lung cancer.

[8]  Stuart Peacock,et al.  Overcoming barriers to priority setting using interdisciplinary methods. , 2009, Health policy.

[9]  A. Mills,et al.  National decision-making on adopting new vaccines: a systematic review. , 2012, Health policy and planning.

[10]  A. Riewpaiboon,et al.  Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. , 2012, Vaccine.

[11]  Stirling Bryan,et al.  Barriers to integrating personalized medicine into clinical practice: a best–worst scaling choice experiment , 2012, Genetics in Medicine.

[12]  Y. Poovorawan,et al.  Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children. , 2010, The Southeast Asian journal of tropical medicine and public health.

[13]  Charles Acquah,et al.  Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  R. Baltussen,et al.  Priority setting of health interventions: the need for multi-criteria decision analysis , 2006, Cost effectiveness and resource allocation : C/E.

[15]  Alfredo Schclarek,et al.  The Case of Chile , 1988, The Battle of Human Rights.

[16]  H. Nohynek,et al.  Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. , 2005, Vaccine.

[17]  Lydia Kapiriri,et al.  Setting priorities for health interventions in developing countries: a review of empirical studies , 2009, Tropical medicine & international health : TM & IH.

[18]  J. Uddin,et al.  Introduction of New Vaccines: Decision-making Process in Bangladesh , 2013, Journal of health, population, and nutrition.

[19]  T. Bärnighausen,et al.  Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  S. Techathawat,et al.  Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study. , 2012, Vaccine.

[21]  T. Kimman,et al.  Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs. , 2006, Vaccine.

[22]  S. Dowell,et al.  Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  Joanna Coast,et al.  Estimating preferences for a dermatology consultation using Best-Worst Scaling: Comparison of various methods of analysis , 2008, BMC medical research methodology.

[24]  Charung Muangchana,et al.  Immunization policy development in Thailand: the role of the Advisory Committee on Immunization Practice. , 2010, Vaccine.

[25]  John F P Bridges,et al.  A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. , 2014, Clinical therapeutics.

[26]  W. Orenstein,et al.  Epidemiologic methods in immunization programs. , 1996, Epidemiologic reviews.

[27]  S. Geiger-Gritsch,et al.  Criteria for vaccine introduction: results of a DELPHI discussion among international immunisation experts on a stepwise decision-making procedure , 2011, Journal of public health.

[28]  Mandy Ryan,et al.  Discrete choice experiments in health economics: a review of the literature. , 2012, Health economics.

[29]  R. Sáez.  The case of Chile , 1960 .

[30]  S. Rojanasuphot,et al.  Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. , 1997, The Southeast Asian journal of tropical medicine and public health.

[31]  S. Rojanasuphot,et al.  Detection of Angiostrongylus malaysiensis circulating antigen using monoclonal antibody-based enzyme-linked immunosorbent assay (MAb-ELISA). , 1997 .

[32]  Andrew Mirelman,et al.  Health care priority setting in Norway a multicriteria decision analysis , 2012, BMC Health Services Research.

[33]  R. Baltussen,et al.  Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences. , 2010, Health policy.

[34]  S. Chunsuttiwat,et al.  Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand. , 2002, Vaccine.

[35]  L. Ericksona,et al.  An analytical framework for immunization programs in Canada , 2005 .

[36]  N. Cameron,et al.  The decision making process on new vaccines introduction in South Africa. , 2012, Vaccine.

[37]  M. Dionne,et al.  Setting priorities for new vaccination programs by using public health officers and immunization managers opinions. , 2008, Vaccine.

[38]  Till Bärnighausen,et al.  Valuing vaccination , 2014, Proceedings of the National Academy of Sciences.

[39]  A. Okoh,et al.  IS6110 Restriction Fragment Length Polymorphism Typing of Drug-resistant Mycobacterium tuberculosis Strains from Northeast South Africa , 2013, Journal of health, population, and nutrition.

[40]  Veronica Vargas,et al.  Health prioritization: the case of Chile. , 2008, Health affairs.

[41]  Elly Stolk,et al.  Towards a multi-criteria approach for priority setting: an application to Ghana. , 2006, Health economics.